1. |
张之南.血液病诊断及疗效标准[M].第2版.北京:科学技术出版社,1998:164165.
|
2. |
沈杨,沈睿,陈钰,等.血液肿瘤合并感染病原菌流行病学及耐药性研究[J].中华血液学杂志,2004,25(6):328332.
|
3. |
HUGHES W T, ARMSTRONG D, BODEY G P. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer[J]. Clin Infect Dis,2002,34(6):730751.
|
4. |
中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651655.
|
5. |
JONES R N. Important and emerging βlactamasemediated resistances in hospitalbased pathogens: the Amp C enzyme [J]. Diagn Microbiol Infect Dis,1998,31(3):462463.
|
6. |
JONES R N, PFALLER M A, DOERN G V, et al. Antimicrobial activity and spectrum inestigation of eight broadspectrum βlactam drugs: a 1997 surveillance trial in102 medical centers in the United States. Cefepime Study Group[J]. Diagn Microbiol Infect Dis,1998,30(3):215228.
|
7. |
WST J, FREI R. Multicenter study of the in vitro activity of cefepime in comparison with five other broad-spectrum antibiotics against clinical isolates of Grampositive and Gramnegative bacteria from hospitalized patients in Switzerland[J]. Clin Microbiol Infect,1999,5(5):262269.
|
8. |
万建华,张静萍,储云卓,等.阿米卡星对产ESBLs大肠埃希菌的体外抗菌活性[J].第四军医大学学报,2004,25(15):13651367.
|
9. |
郑卫.氨基糖甙类抗生素研究新进展[J].国外医学抗生素分册,2005,26(3):101.
|
10. |
陈雪融,姚蓉,梁宗安,等.盐酸头孢吡肟治疗下呼吸道感染和泌尿系感染的多中心随机对照临床研究[J].华西药学杂志,2007,22(4):457458.
|